Abstract Aims Advanced glycation endproducts (AGEs) are sugar-modified adducts which
arise during non-enzymatic glycoxidative stress. These compounds may become …

Diabetes mellitus (DM), due to its long-term hyperglycemia, leads to the accumulation of
advanced glycation end-products (AGEs), especially in the vessel walls. Skin …

Background Advanced glycation end products (AGEs) have been linked to cardiovascular
disease (CVD), especially coronary heart disease (CHD), but their role in CVD pathogenesis …

Endometriosis is a prevalent gynecological condition, affecting around 10% of reproductive-
age women. Inflammatory processes associated with endometriosis may contribute to …

Background Chronic kidney disease (CKD) is a very common long-term condition and
powerful risk factor for cardiovascular disease (CVD). Low-dose aspirin is of proven benefit …

Advanced glycation end products (AGEs) disturb endothelial barrier function and contribute
to age-related diseases. As microRNAs (miRNAs) are potential therapeutic agents, targeting …

Cardiometabolic disorders are characterised by a cluster of interactive risk determinants
such as increases in blood glucose, lipids and body weight, as well as elevated …

Background and aims Skin autofluorescence (SAF) can non-invasively assess the
accumulation of tissue AGEs. We investigated the association between SAF and kidney …

Aims This meta-analysis aimed to systematically evaluate the prospective association
between advanced glycation end products (AGEs) and major adverse cardiovascular events …

The incidence and prevalence of diabetes are increasing worldwide, and cardiovascular
disease (CVD) is the leading cause of death among subjects with type 2 diabetes (T2D). The …